InsidersTradesSigma
Discover the complete record of transactions filed by Min Kwan-Hong Christopher, Directeur Médical. Director active across 1 company, notably Longeveron Inc.. Cumulatively, 2 reports have been published. History available since 4 April 2022. The latest transaction was filed on 4 April 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations
Christopher Kwan-Hong Min is the Chief Medical Officer at Longeveron Inc. He is responsible for medical strategy and product development. Christopher plays a key role in innovation and improving healthcare. His expertise in medicine and clinical research is essential for Longeveron's success.